๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Thymosin-ฮฑ1 for Recurrent Implantation Failure

RecruitingPhase 2, Phase 3Ages 18 Years - 40 YearsFemaleFakih IVF Fertility Center
NCT07675980 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Clinical trial evaluating the safety and efficacy of Thymosin-ฮฑ1 (Tฮฑ1) as an adjunctive immunomodulatory therapy in women with unexplained recurrent implantation failure (RIF) undergoing IVF/ICSI cycles.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. -Women 18-40 years 2. -RIF- โ‰ฅ2 failed embryo transfers with PGT-a tested euploid embryos 3. \- Normal parental karyotypes 4. \- Normal uterine cavity on imaging 5. \- Negative antiphospholipid panel 6. \- Thyroid and prolactin controlled within local reference standards Exclusion Criteria: 1. Identified/correctable non-immune cause of RPL (chromosomal, anatomic, endocrine) 2. \- Active malignancy 3. -Active infection 4. \- Uncontrolled systemic disease 5. \- Current systemic immunosuppression
๐Ÿ’Š

What it tests

  • Thymosin Alpha1
  • Placebo Control
๐Ÿ“

Where

1 site
Fakih IVF
Abu Dhabi, United Arab Emirates
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy